Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
-
The FDA cited administrative constraints for the delay, Cambridge,
Mass.-based Moderna said in a statement.
5 minutes ago
While the company had good intentions, it just goes to show that social media can be a company’s best and worst friend. The best way to solve this is to author a protocol with consistent practices for all situations. Crisis management always needs to be present in an ever-changing medium like the internet.
ReplyDelete